DENTSPLY Sirona Inc (XRAY) concluded trading on Thursday at a closing price of $15.00, with 3.83 million shares of worth about $57.42 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -40.18% during that period and on March 13, 2025 the price saw a loss of about -2.15%. Currently the company’s common shares owned by public are about 198.80M shares, out of which, 197.66M shares are available for trading.
Stock saw a price change of -7.75% in past 5 days and over the past one month there was a price change of -17.94%. Year-to-date (YTD), XRAY shares are showing a performance of -20.97% which decreased to -55.71% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $15.30 but also hit the highest price of $34.28 during that period. The average intraday trading volume for DENTSPLY Sirona Inc shares is 2.72 million. The stock is currently trading -13.19% below its 20-day simple moving average (SMA20), while that difference is down -17.98% for SMA50 and it goes to -33.38% lower than SMA200.
DENTSPLY Sirona Inc (NASDAQ: XRAY) currently have 198.80M outstanding shares and institutions hold larger chunk of about 102.74% of that.
The stock has a current market capitalization of $2.98B and its 3Y-monthly beta is at 0.92. It has posted earnings per share of -$4.55 in the same period. It has Quick Ratio of 0.74 while making debt-to-equity ratio of 1.17. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for XRAY, volatility over the week remained 3.59% while standing at 3.86% over the month.
Stock’s fiscal year EPS is expected to rise by 9.21% while it is estimated to increase by 11.52% in next year.
Coverage by Wells Fargo stated DENTSPLY Sirona Inc (XRAY) stock as an Equal weight in their note to investors on February 14, 2025, suggesting a price target of $20 for the stock. On January 23, 2025, Jefferies Downgrade their recommendations, while on January 07, 2025, Evercore ISI Downgrade their ratings for the stock with a price target of $20. Stock get a Neutral rating from Mizuho on December 04, 2024.
